Covid-19 roundup: US and Pfizer strike deal for 100M more doses; NIH and partners cut critically ill patients out of blood thinner trial

Nicole DeFeudis

Editor

The US government has sealed a deal with Pfizer and BioNTech for 100 million additional doses of their Covid-19 vaccine, doubling the country’s dose order …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: US and Pfizer strike deal for 100M more doses; NIH and partners cut critically ill patients out of blood thinner trial

Nicole DeFeudis

Editor

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA approves first drug to treat ultra-rare lipid storage disease

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Covid-19 roundup: US and Pfiz­er strike deal for 100M more dos­es; NIH and part­ners cut crit­i­cal­ly ill pa­tients out of blood thin­ner tri­al

Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Covid-19 roundup: US and Pfizer strike deal for 100M more doses; NIH and partners cut critically ill patients out of blood thinner trial